InMed Pharmaceuticals, Inc. (INM)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
Oct 02, 16:00
1.333
0.00 (0.00%)
After-Hours: 20:00
InMed Pharmaceuticals Net Income (Quarterly) : -4.843M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.843M |
| March 31, 2026 | -2.792M |
| December 31, 2025 | -2.028M |
| September 30, 2025 | -1.727M |
| June 30, 2025 | -1.835M |
| March 31, 2025 | -2.067M |
| December 31, 2024 | -2.575M |
| September 30, 2024 | -1.678M |
| June 30, 2024 | -1.938M |
| March 31, 2024 | -1.723M |
| December 31, 2023 | -1.478M |
| September 30, 2023 | -2.537M |
| June 30, 2023 | -0.3384M |
| March 31, 2023 | -1.998M |
| December 31, 2022 | -2.101M |
| September 30, 2022 | -3.510M |
| June 30, 2022 | -7.87M |
| March 31, 2022 | -3.476M |
| December 31, 2021 | -4.283M |
| September 30, 2021 | -2.972M |
| June 30, 2021 | -3.259M |
| March 31, 2021 | -3.102M |
| December 31, 2020 | -1.722M |
| September 30, 2020 | -1.599M |
| June 30, 2020 | -1.616M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.024M |
| December 31, 2019 | -2.538M |
| September 30, 2019 | -2.943M |
| June 30, 2019 | -3.191M |
| March 31, 2019 | -2.626M |
| December 31, 2018 | -2.009M |
| September 30, 2018 | -2.174M |
| June 30, 2018 | -2.346M |
| March 31, 2018 | -1.682M |
| December 31, 2017 | -1.214M |
| September 30, 2017 | -1.452M |
| June 30, 2017 | -1.395M |
| March 31, 2017 | -0.9377M |
| December 31, 2016 | -0.7039M |
| September 30, 2016 | -0.3205M |
| June 30, 2016 | -0.3915M |
| March 31, 2016 | -0.2784M |
| December 31, 2015 | -0.5805M |
| September 30, 2015 | -0.5298M |
| June 30, 2015 | -1.179M |
| March 31, 2015 | -1.308M |
| December 31, 2014 | -0.4986M |
| September 30, 2014 | -0.5993M |
| June 30, 2014 | -0.9888M |
| March 31, 2014 | -0.0925M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| NervGen Pharma Corp. | -21.10M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
| Clearmind Medicine, Inc. | -0.9073M |
| Lexaria Bioscience Corp. | -1.993M |
| Target Group, Inc. (Canada) | -0.2398M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.843M |
| EPS Diluted (Quarterly) | -1.434 |
| Enterprise Value | 4.867M |
| Earnings Yield | -234.3% |
| Normalized Earnings Yield | -214.48 |